Epigenetic Mechanisms in Cellular Reprogramming: Epigenetics and Human Health
Editat de Alexander Meissner, Jörn Walteren Limba Engleză Hardback – 5 ian 2015
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 713.18 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 24 sep 2016 | 713.18 lei 6-8 săpt. | |
Hardback (1) | 720.10 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 5 ian 2015 | 720.10 lei 6-8 săpt. |
Preț: 720.10 lei
Preț vechi: 758.01 lei
-5% Nou
Puncte Express: 1080
Preț estimativ în valută:
137.83€ • 142.04$ • 116.36£
137.83€ • 142.04$ • 116.36£
Carte tipărită la comandă
Livrare economică 04-18 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642319730
ISBN-10: 3642319734
Pagini: 250
Ilustrații: XVIII, 230 p. 20 illus., 19 illus. in color.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.53 kg
Ediția:2015
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Epigenetics and Human Health
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642319734
Pagini: 250
Ilustrații: XVIII, 230 p. 20 illus., 19 illus. in color.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.53 kg
Ediția:2015
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Epigenetics and Human Health
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchTextul de pe ultima copertă
The ability of a single genome to give rise to hundreds of functionally distinct cell type programs is in itself remarkable. Pioneering studies over the past few decades have demonstrated that this plasticity is retained throughout development, a phenomenon of epigenetic programming and reprogramming that remains one of the most fascinating areas of modern biology, with major relevance to human health and disease. This book presents the basic biology involved, including key mechanistic insights into this rapidly growing field.
Caracteristici
Contains translational medicine aspects such as B cell programming and reprogramming in cancer Includes extensive glossary Understanding stem cell formation is key to develop novel drugs